Last Articles

We are very happy to create this affiliation agreement with CDRD.

By combining their discoveries with CDRD’s full drug development platform, we will be further positioned to accomplish our objective of translating educational discoveries into new medicines,’ stated Natalie Dakers, CEO, CDRD.. CDRD, University of Ottawa indication affiliation agreement for drug development platform The University of Ottawa and the Center for Drug Research and Advancement today announced that they have signed an affiliation agreement which will allow researchers at the University of Ottawa to access CDRD’s drug development infrastructure and expertise.Related StoriesPresence of connexin proteins suppresses main tumor growthRice researchers solve long-standing up mystery about hemophilia proteinGenvoya accepted as comprehensive regimen for HIV treatment Since then, additional information possess emerged about Nef's function. HIV enters disease fighting capability cells with a receptor known as CD4, but once HIV enters cells through the CD4 door, it slams the entranceway shut behind itself to avoid unproductive re-infection, Hurley said. Researchers aren't sure why HIV slams the entranceway on other viruses, he said, though it might be a real way to avoid too many viruses getting into the same cell, producing the cellular environment much less favorable intended for productive viral replication.